RaNA Therapeutics Receives $50,999,987 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8ac4bfcb-fc72-4fdd-8e08-6373931a6816 - Date
1/6/2017 - Company Name
RaNA Therapeutics - Mailing Address
200 Sidney Street Cambridge, MA 02139 USA - Company Description
RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA’s technology upregulates the expression of desirable genes that can prevent or treat disease. - Website
http://www.ranarx.com - Transaction Type
Venture Equity - Transaction Amount
$50,999,987 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 25 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
